Labetalol Hcl Mylan

Labetalol Hydrochloride, the active ingredient in Labetalol Hcl Mylan, is a non‑selective beta blocker with alpha‑1 antagonist activity presented as an oral tablet for oral use. It treats hypertension and hypertensive emergencies in adult patients. GNH USA supplies Labetalol Hcl Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Labetalol Hydrochloride is used to manage conditions involving elevated blood pressure and related cardiovascular stress. - Hypertension: lowers systemic blood pressure in patients with essential hypertension. - Hypertensive emergencies: provides rapid blood pressure control in acute, severe hypertension. - Aortic dissection: helps achieve target blood pressure to reduce shear stress on the aortic wall.

Labetalol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after dose initiation. - Fatigue: generalized tiredness or lack of energy. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach upset or urge to vomit.

Serious or Rare Side Effects: - Bronchospasm: tightening of airway muscles, particularly in patients with asthma. - Severe hypotension: dangerously low blood pressure requiring medical attention. - Hepatic dysfunction: abnormal liver enzyme elevations or hepatitis. - Cardiac conduction abnormalities: heart block or severe bradycardia.

Before prescribing Labetalol, clinicians should consider several safety measures. - Blood pressure monitoring: regularly check to avoid excessive hypotension. - Asthma or COPD: use with caution as beta‑blockade may worsen bronchospasm. - Abrupt discontinuation: taper gradually to prevent rebound hypertension. - Liver impairment: adjust dosing and monitor hepatic function. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Labetalol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Other antihypertensives (e.g., clonidine): may cause profound hypotension. - Calcium channel blockers (verapamil): additive blood pressure lowering effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive response. - Diuretics: can enhance electrolyte disturbances. - Antidiabetic agents: may mask hypoglycemia symptoms.